Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Authors' conclusions are at odds with investigators'
| The first 150 words of the full text of this article appear below. |
EDITOR
In responding to Jefferson's editorial about vaccination
and its adverse effects Classen and Classen say that present immunisation schedules may exacerbate the development of type 1 diabetes and that early immunisation with a cocktail of vaccines may
prevent the development of diabetes.
1 2
The authors cite their unpublished reanalysis of the Finnish trial of
Haemophilus influenzae type b vaccine.3
Their conclusions are at odds with the analyses and conclusions of the
investigator (JT) presented at a National Institutes of Health workshop
and were published recently.4 The Finnish investigators'
review of the data could not attribute the risk of type 1 diabetes in Finnish children to differences in the timing of childhood vaccination in the vaccine trial. The incidence of type 1 diabetes in Finland has
risen over several decades, and the risk seems to have been almost
linear since the early 1950s. Given the disparity of conclusions, it
was suggested that Classen
Read all Rapid Responses